Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy

World Journal of Gastroenterology

Volumn , Issue 26, 2014, Pages 8653-8659

  Ma, Hong ^a   Hasim, Ayshamgul ^a   Mamtimin, Batur ^a   Kong, Bin ^b   Zhang, Hai Ping ^a   Sheyhidin, Ilyar ^a  

^a Medical University of Xinjiang   (China)

^b Pharmacy Department of Production and Construction Corps General Hospital of Xinjiang   (China)

Author keywords

Amino acids; Esophageal squamous cell cancer; High performance liquid chromatography; Metabolomics; Plasma

Indexed keywords

ALANINE; AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; CYSTEINE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TYROSINE; VALINE; CYSTINE; GLUTAMINE; LYSINE; PLASMA FREE AMINO ACID; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER SCREENING; CANCER STAGING; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR DIFFERENTIATION; VERY ELDERLY; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; CHROMATOGRAPH; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; BLOOD; CANCER GRADING; CASE CONTROL STUDY; CELL DIFFERENTIATION; ESOPHAGUS TUMOR; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROCEDURES; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; LYMPHATIC METASTASIS; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TUMOR MARKERS, BIOLOGICAL;

EID: 84904382613     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i26.8653     Document Type: Article

References (29)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150 [PMID: 16682732] (Pubitemid 46655601)
2. Ruol A, Castoro C, Portale G, Cavallin F, Sileni VC, Cagol M, Alfieri R, Corti L, Boso C, Zaninotto G, Peracchia A, Ancona E. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg 2009; 144: 247-254; discussion 254 [PMID: 19289664 DOI: 10.1001/archsurg.2008.574]
3. Zhang YM. The distribution of esophageal cancer in Xinjiang. Xinjiang Yike Daxue Xuebao 1988; 11: 139-144
4. Koshy M, Esiashvilli N, Landry JC, Thomas CR, Matthews RH. Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist 2004; 9: 147-159 [PMID: 15047919] (Pubitemid 38452114)
5. Lambert R, Hainaut P. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol 2007; 21: 921-945 [PMID: 18070696]
6. Altman BJ, Dang CV. Normal and cancer cell metabolism: lymphocytes and lymphoma. FEBS J 2012; 279: 2598-2609 [PMID: 22672505 DOI: 10.1111/j.1742-4658.2012.08651.x]
7. Lai HS, Lee JC, Lee PH, Wang ST, Chen WJ. Plasma free amino acid profile in cancer patients. Semin Cancer Biol 2005; 15: 267-276 [PMID: 15894488]
8. Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, Miura T, Saruki N, Bando E, Kimura H, Imamura F, Moriyama M, Ikeda I, Chiba A, Oshita F, Imaizumi A, Yamamoto H, Miyano H, Horimoto K, Tochikubo O, Mitsushima T, Yamakado M, Okamoto N. Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One 2011; 6: e24143 [PMID: 21915291 DOI: 10.1371/journal.pone.0024143]
9. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181-1189 [PMID: 10598751]
10. Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genomics 2001; 2: 155-168 [PMID: 18628911 DOI: 10.1002/cfg.82] (Pubitemid 32590962)
11. Chadeau-Hyam M, Ebbels TM, Brown IJ, Chan Q, Stamler J, Huang CC, Daviglus ML, Ueshima H, Zhao L, Holmes E, Nicholson JK, Elliott P, De Iorio M. Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification. J Proteome Res 2010; 9: 4620-4627 [PMID: 20701291 DOI: 10.1021/pr1003449]
12. Hasim A, Ali M, Mamtimin B, Ma JQ, Li QZ, Abudula A. Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy. Exp Ther Med 2012; 3: 945-951 [PMID: 22969997]
13. Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 2009; 15: 431-440 [PMID: 19147747 DOI: 10.1158/1078-0432.CCR-08-1059]
14. Mamas M, Dunn WB, Neyses L, Goodacre R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol 2011; 85: 5-17 [PMID: 20953584 DOI: 10.1007/s00204-010-0609-6]
15. Shimbo K, Kubo S, Harada Y, Oonuki T, Yokokura T, Yoshida H, Amao M, Nakamura M, Kageyama N, Yamazaki J, Ozawa S, Hirayama K, Ando T, Miura J, Miyano H. Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry. Biomed Chromatogr 2010; 24: 683-691 [PMID: 19830681 DOI: 10.1002/bmc.1346]
16. 1H-NMR spectroscopy and its association with the clinicopathological characteristics. Mol Biol Rep 2012; 39: 8955-8964 [PMID: 22736106 DOI: 10.1007/s11033-012-1764-z]
17. Kubota A, Meguid MM, Hitch DC. Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors. Cancer 1992; 69: 2343-2348 [PMID: 1562982]
18. Shingyoji M, Iizasa T, Higashiyama M, Imamura F, Saruki N, Imaizumi A, Yamamoto H, Daimon T, Tochikubo O, Mitsushima T, Yamakado M, Kimura H. The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer. BMC Cancer 2013; 13: 77 [PMID: 23409863 DOI: 10.1186/1471-2407-13-77]
19. Wang L, Chen J, Chen L, Deng P, Bu Q, Xiang P, Li M, Lu W, Xu Y, Lin H, Wu T, Wang H, Hu J, Shao X, Cen X, Zhao YL. 1H-NMR based metabonomic profiling of human esophageal cancer tissue. Mol Cancer 2013; 12: 25 [PMID: 23556477 DOI: 10.1186/1476-4598-12-25]
20. Garber K. Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst 2004; 96: 1805-1806 [PMID: 15601632] (Pubitemid 40081310)
21. Phang JM, Liu W, Hancock C. Bridging epigenetics and metabolism: role of non-essential amino acids. Epigenetics 2013; 8: 231-236 [PMID: 23422013 DOI: 10.4161/epi.24042]
22. Ong ES, Zou L, Li S, Cheah PY, Eu KW, Ong CN. Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis. Mol Cell Proteomics 2010; Epub ahead of print [PMID: 20147338]
23. de Aguiar Picanc¸o E, Lopes-Paulo F, Marques RG, Diestel CF, Caetano CE, de Souza MV, Moscoso GM, Pazos HM. L-arginine and glycine supplementation in the repair of the irradiated colonic wall of rats. Int J Colorectal Dis 2011; 26: 561-568 [PMID: 21350937 DOI: 10.1007/s00384-011-1154-3]
24. Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL, Kafri R, Kirschner MW, Clish CB, Mootha VK. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012; 336: 1040-1044 [PMID: 22628656 DOI: 10.1126/science.1218595]
25. Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J. Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Physiol 1998; 274: E817-E826 [PMID: 9612239]
26. Tessem MB, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, Simko JP, Shinohara K, Nelson SJ, Vigneron DB, Gribbestad IS, Kurhanewicz J. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HRMAS spectroscopy of biopsy tissues. Magn Reson Med 2008; 60: 510-516 [PMID: 18727052 DOI: 10.1002/mrm.21694]
27. Moreadith RW, Lehninger AL. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. J Biol Chem 1984; 259: 6215-6221 [PMID: 6144677] (Pubitemid 14106333)
28. Leichtle AB, Nuoffer JM, Ceglarek U, Kase J, Conrad T, Witzigmann H, Thiery J, Fiedler GM. Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics 2012; 8: 643-653 [PMID: 22833708]
29. Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. World J Gastroenterol 2013; 19: 7620-7629 [PMID: 24282351 DOI: 10.3748/wjg.v19.i43.7620]